Citation: B. Sundmanengberg et al., EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 255-260
Citation: B. Sundmanengberg et al., TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 17-23
Authors:
MOLLGARD L
TIDEFELT U
SUNDMANENGBERG B
LOFGREN C
LEHMAN S
PAUL C
Citation: L. Mollgard et al., HIGH SINGLE-DOSE OF MITOXANTRONE AND CYTARABINE IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHARMACOKINETIC AND CLINICAL-STUDY, Therapeutic drug monitoring, 20(6), 1998, pp. 640-645
Authors:
BJORKSTRAND B
SMITH CIE
SUNDBERG M
SUNDMANENGBERG B
DILBER MS
LJUNGMAN P
GAHRTON G
Citation: B. Bjorkstrand et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH GENE MARKED CELLS IN MULTIPLE-MYELOMA, Cancer gene therapy, 4(5), 1997, pp. 331-331
Authors:
PAUL C
TIDEFELT U
GRUBER A
LILIEMARK E
SUNDMANENGBERG B
JULIUSSON G
STENKE L
ELMHORNROSENBORG A
MOLLGARD L
LEHMANN S
COVELLI A
MALKHANDI J
GUSTAVSSON B
LILIEMARK J
Citation: C. Paul et al., THE P-GLYCOPROTEIN INHIBITOR (PGP) PSC-833 INCREASES THE INTRACELLULAR CONCENTRATIONS OF DAUNORUBICIN (DNR) IN-VIVO IN PATIENTS WITH PGP POSITIVE AML, Blood, 90(10), 1997, pp. 805-805
Citation: B. Sundmanengberg et al., EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS ON LEUKEMIC-CELLS IN-VITRO AND IN-VIVO, European journal of haematology, 56(1-2), 1996, pp. 1-6
Citation: U. Tidefelt et al., COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DAUNORUBICIN AND IDARUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA, Leukemia research, 18(4), 1994, pp. 293-297
Authors:
SUNDMANENGBERG B
TIDEFELT U
GRUBER A
PAUL C
Citation: B. Sundmanengberg et al., INTRACELLULAR CONCENTRATIONS OF MITOXANTRONE IN LEUKEMIC-CELLS INVITRO VS INVIVO, Leukemia research, 17(4), 1993, pp. 347-352